Author:
Weickert T W,Weinberg D,Lenroot R,Catts S V,Wells R,Vercammen A,O'Donnell M,Galletly C,Liu D,Balzan R,Short B,Pellen D,Curtis J,Carr V J,Kulkarni J,Schofield P R,Weickert C S
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology
Reference75 articles.
1. Levine SZ, Rabinowitz J, Ascher-Svanum H, Faries DE, Lawson AH . Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: evidence from the CATIE study. Schizophr Res 2011; 133: 42–46.
2. Weickert TW, Goldberg TE . The course of cognitive impairment in patients with schizophrenia. In: Sharma T, Harvey P (eds). Cognition in Schizophrenia: Impairments, importance and treatment strategies. Oxford University Press: New York, NY, 2000; 3–15.
3. Green MF . What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153: 321–330.
4. Hyman SE . Revitalizing psychiatric therapeutics. Neuropsychopharmacology 2014; 39: 220–229.
5. Burke KC, Burke JD Jr, Regier DA, Rae DS . Age at onset of selected mental disorders in five community populations. Arch Gen Psychiatry 1990; 47: 511–518.
Cited by
119 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献